WHO ICTRP trial

The effects of creatine supplementation and weight training on muscle mass in…

ACTRN12619000099123 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12619000099123
Public title The effects of creatine supplementation and weight training on muscle mass in individuals with prostate cancer undergoing androgen deprivation therapy.
Scientific title Examining the effect of creatine supplementation in augmenting adaptations to resistance training in prostate cancer patients undergoing androgen deprivation therapy: a randomized, double-blind, placebo controlled trial.
Primary sponsor Edith Cowan University
Secondary sponsors Ciaran Fairman
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Not Applicable
Countries Australia
Conditions Prostate Cancer; Prostate Cancer;Physical Medicine / Rehabilitation - Other physical medicine / rehabilitation;Cancer - Prostate
Interventions Study Design This is a double-blind randomised controlled trial designed to measure the effects of creatine (Cr) supplementation in addition to resistance training (RT) in prostate cancer (PCa) patients receiving androgen deprivation…
Registration date Jan 23, 2019
Target size 56
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations